An Open, Single-center, Safety and Efficacy Study of Conbercept in Patients With Very Low Vision Secondary to Wet Age-related Macular Degeneration (wAMD)

NCT02098720 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Very Low Vision Secondary to Wet Age-related Macular Degeneration

Interventions

DRUG: Conbercept

Sponsor

Chengdu Kanghong Biotech Co., Ltd.